Evidence map›Paper›PMID 24605059›Full record

ArticleTheScientificWorldJournal2014

Thapsigargin induces apoptosis by impairing cytoskeleton dynamics in human lung adenocarcinoma cells.

Fei Wang, Da-zhong Liu, Hao Xu, Yi Li, Wei Wang, Bai-lu Liu, Lin-you Zhang

Abstract read
In one paragraph

Article in TheScientificWorldJournal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Depletion ofFrontiers in molecular biosciences · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Significance of Trask protein interactions in brain metastatic cohorts of lung cancers.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fei WangDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu, Nangang District, Harbin 150086, China.
Da-zhong LiuDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu, Nangang District, Harbin 150086, China.
Hao XuDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu, Nangang District, Harbin 150086, China.
Yi LiDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu, Nangang District, Harbin 150086, China.
Wei WangDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu, Nangang District, Harbin 150086, China.
Bai-lu LiuDepartment of Computerized Tomography, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu, Nangang District, Harbin 150086, China.
Lin-you ZhangDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu, Nangang District, Harbin 150086, China.ORCID 0000-0001-7650-7519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was performed to investigate the effects of thapsigargin on apoptosis, actin cytoskeletal dynamics, and actin cytoskeletal proteins in human lung adenocarcinoma cell. Thapsigargin is a specific irreversible inhibitor of ER calcium-ATPase, which may promote ER stress by depletion of lumenal calcium stores and show potential to induce cell death. The effects of thapsigargin on the apoptosis in A549 cells were assayed by Hoechst staining. Moreover, the F-actin staining by Rhodamine-phalloidin and RhoA antibody for cytoskeleton organizations were applied to A549 cells. To confirm the impairment of cytoskeletal dynamics treated with thapsigargin, western blots were applied to analyze the protein levels of p-Cofilin-1 (Ser3), Cofilin-1, and pPaxillin (Tyr118), as well as RhoA and pS6 (S240/244). Results suggest that thapsigargin may induce cell death in A549 cells with a time- and dose-dependent manner. The F-actin fibers and RhoA signals are also reduced with a time- and dose-dependent manner by thapsigargin treatment. The phosphorylation forms of Cofilin-1 and paxillin are attenuated by 1 μM thapsigargin treatment for 24 h. These alternations may be caused by the inhibition of of mTORC1 activities (indicated by pS6 (Ser240/244)) and RhoA pathways after thapsigargin treatment. The present findings highlight important roles of calcium entry in cytoskeleton organization and apoptosis in human lung adenocarcinoma cells and will help to set a stage to the clinical treatment of cancer cell metastasis.

Indexed as

AdenocarcinomaApoptosisBlotting, WesternCalciumCalcium-Transporting ATPasesCell Line, TumorCofilin 1Cytoskeletal ProteinsCytoskeletonEndoplasmic Reticulum StressHumansLung NeoplasmsPaxillinThapsigarginCalciumCalcium-Transporting ATPasesCofilin 1Cytoskeletal ProteinsPaxillinThapsigargin

Identifiers

PMID24605059
PMCPMC3926280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.